Back to Leadership

Richard A. Meier

  • Chair, BioMarin Board of Directors
  • Supervisory Board Member, Syntellix AG

Committee(s):

  • Strategic and Operating Review

LinkedIn

Richard A. Meier has served as the Chair of BioMarin’s Board of Directors since December 2023 and a director since December 2006. Before becoming the Chair of our Board, he served as our Lead Independent Director from June 2015 to November 2023.

Mr. Meier served as President and Chief Executive Officer and a member of the board of Rockley Photonics Holdings Ltd., a public medical technology company, from December 2022 to May 2023 and as President and Chief Financial Officer from October 2022 to December 2022.

Prior to Rockley, Mr. Meier is Executive Vice President and Chief Financial Officer of Intersect ENT, Inc., a position he has held since November 2019 through June 2022 when it was acquired by Medtronic. Mr. Meier served as Executive Vice President and Chief Financial Officer of Owens & Minor, Inc. from March 2013 to July 2015. In July 2015, he took on the added role of President-International, a position he held until July 2018. Earlier in his career, Mr. Meier served as President and Chief Operating Officer of Advanced Medical Optics, Inc., a global ophthalmic medical device company, that was acquired by Abbott Laboratories in February 2009. Throughout his time at Advanced Medical Optics, Mr. Meier served as Chief Financial Officer, while also serving in several additional senior operating roles. In addition, Mr. Meier held the position of Chief Financial Officer at a number of global healthcare companies, including TeleFlex Incorporated and Bausch Health Companies, Inc. (formerly Valeant Pharmaceuticals, Inc. and ICN Pharmaceuticals, Inc.). Before these healthcare industry roles, Mr. Meier was an executive with the investment banking firm of Schroder & Co. Inc. in New York. Prior to Mr. Meier’s experience at Schroder & Co., he held various financial and banking positions at Salomon Smith Barney, Manufacturers Hanover Corporation, Australian Capital Equity, and Greyhound Lines, Inc.

Mr. Meier is a member of the Supervisory Board of Syntellix AG and he was a director of Staar Surgical Inc. from June 2009 to June 2016, where he also served on the Governance, Compensation, and Audit Committees.

Mr. Meier holds a B.A. in Economics from Princeton University.